|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o AMDL Inc., of Tustin, Calif., said AMDL Australia Pty. Ltd., its Down Under distributor, began selling its DR-70 cancer detection test in Australia and New Zealand. The non-intrusive blood test is designed to detect and monitor 13 types of cancer from a single blood serum sample.
o Amylin Pharmaceuticals Inc., of San Diego, said it repaid early its outstanding loans to Johnson & Johnson, of New Brunswick, N.J. Amylin paid J&J $62.5 million, representing a 7 percent discount to the total loan obligation as of the repayment date. The loans were made before 1998 through an earlier collaboration on Amylin's Symlin (pramlintide acetate) and they collectively accrued ...
Related newspaper, magazine, and journal articles:
|
|
Article: MEGABIOS, GENEMEDICINE AGREE TO `STRATEGIC MERGER' THAT POOLS ...
BIOWORLD Today;
October 27, 1998 ;
700+ words
... ... percent, or $0.281. McGraw told BioWorld Today the move is one of the few "strategic ... into GeneMedicine," Weintraub told BioWorld Today. "This merger allows us to simplify ... up relatively early," Waldron told BioWorld Today. "This merger announcement is the ...
|
|